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Abstract
Background: The association of the tissue characteristics of carotid plaques with coronary artery disease has
attracted interest. The present study compared the tissue characteristics of carotid plaques in patients with acute
coronary syndrome (ACS) with those in patients with stable angina pectoris (SAP) using the iPlaque system, which
is based on ultrasound integrated backscatter.
Methods and results: Carotid ultrasound examinations were performed in 26 patients with ACS, and 38
age- and gender-matched patients with SAP. Neither plaque area nor maximal intima-media thickness differed
significantly between the two groups. However, the average integrated backscatter value within the plaque
was greater in the ACS patients than in the SAP patients. iPlaque analysis revealed that the percentage blue
area (lipid pool) was greater in the ACS patients than in the SAP patients (43.4 ± 11.2 vs 18.3 ± 10.3 %,
p < 0.0001), and that the percentage green area (fibrosis) was lower in the ACS than in the SAP patients
(7.5 ± 7.5 % vs 20.7 ± 11.7 %, p < 0.0001).
Conclusions: The lipid component of carotid plaques is greater in ACS patients than in SAP patients. Our
iPlaque system provides a useful and feasible method for the tissue characterization of carotid plaques in the
clinical setting.
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Background
Recent developments in imaging technology, such as
intravascular ultrasound (IVUS) and optical coherence
tomography, enable us to obtain information on coron-
ary plaques in patients [1, 2].Through numerous inves-
tigations using these imaging devices, it has become
recognized that a lipid-rich plaque in the coronary ar-
tery is vulnerable, and can precede the development of
acute coronary syndrome (ACS) [3–6]. Quantitative
analysis of tissue characteristics of coronary plaques
has been achieved by IVUS with integrated backscatter
(IB) ultrasound analysis [7] and this technique has
been used in large multicenter clinical studies [8]. IB-
IVUS enables the identification of the histological fea-
tures of coronary plaques, such as lipid pools, fibrous
tissue, and calcified tissue [9].
The tissue composition of carotid plaques has been re-
ported to predict the risk of cerebrovascular and cardiovas-
cular events [10–12]. Patients with ACS were found to
have unstable atherosclerotic plaques in carotid arteries
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[13, 14]. In carotid ultrasonography, the video density of
plaque measured as gray scale median has been used to
quantify the tissue characteristics of plaques. [15–17] Some
investigators have also applied the IB ultrasound technique
to carotid plaques [18–20] however, it has not been used
clinically.
To transfer this knowledge to the clinical setting,
we have developed the iPlaque system [21], an ultra-
sound IB-based image analysis software that enables
the tissue components of carotid plaques to be visu-
alized with high resolution in a color-coded display.
It also quantifies the proportions of each tissue com-
ponent in the plaque. The system provides tissue
characterization similar to that attainable with IB-
IVUS, which is based on percutaneous carotid ultra-
sonography. It has been validated by comparison
with the results of histology of samples of plaques
taken from patients during carotid endarterectomy
(CEA) [22].
The purpose of this study was to compare the tis-
sue characteristics of carotid plaques in patients with
ACS with those in patients with stable angina pectoris
(SAP) using our iPlaque system, which eventually es-




From 195 patients who had undergone percutaneous
coronary intervention and carotid ultrasonography in
our department from January 2010 to June 2014, pa-
tients with suitable carotid plaques for iPlaque analysis
were enrolled in this study. The selection criteria for
suitable iPlaque analysis were as follows: (1) maximal
intima-media thickness (IMT) of the plaque ≥ 1.5 mm,
(2) located in either the common or internal carotid ar-
tery, (3) located in the far wall, and (4) without severe
stenosis (defined as > 75 % area stenosis). Of them, 26
patients were diagnosed as having ACS, and 169 were
diagnosed with SAP. The ACS group included 8 patients
with ST elevation myocardial infarction, 12 patients with
non-ST elevation myocardial infarction, and 4 patients
with unstable angina pectoris. To compare the tissue
characteristics of the carotid artery with those in the
26 ACS patients, 38 age- and gender-matched sub-
jects were randomly selected from the SAP patients.
If the true difference of average IB values of carotid
plaque in the ACS and SAP is 2.0 with standard devi-
ation 2.5 according to a previous study [13], our sam-
ple size were enough to reject the null hypothesis
that the population means of the ACS and SAP
groups are equal with probability (power) 0.85. The
Type I error probability associated with this test of this
null hypothesis is 0.05.
Definition of diseases
ACS included acute myocardial infarction and unstable
angina pectoris. The diagnosis of acute myocardial in-
farction was made if the patient had typical chest pain
with characteristic electrocardiogram changes and eleva-
tion of at least one positive biomarker (creatinine kinase
[CK], CK-MB, or troponin T). A diagnosis of unstable
angina pectoris was made when there was angina with a
progressive crescendo pattern, or angina that occurred
at rest. SAP was defined as no episodes of angina at rest
in a patient who underwent percutaneous coronary
intervention more than six months previously. Hyperten-
sion was defined as a systolic blood pressure >140 mmHg
and/or a diastolic pressure >90 mmHg, or current treat-
ment with antihypertensive medication. Diabetes was de-
fined as a fasting blood glucose ≥126 mg/dl, hemoglobin
A1c ≥6.5 %, and/or the need for oral hypoglycemic agents
or insulin. Hyperlipidemia was defined as plasma total
cholesterol >220 mg/dl or the use of lipid-lowering
therapy. Smoking was defined as current or previous
smoking [23].
Study protocols
Carotid ultrasound examinations were performed using
the Logiq 7 with a 10 MHz linear-array transducer (GE
Healthcare, Milwaukee, WI, USA). All carotid scans
were performed by a single well-trained operator, who
had no information on the clinical characteristics of the
patients. The position of the probe was adjusted so
that the ultrasonic beam was vertical to the artery
wall, and maximal IMT was measured manually in
the common carotid artery, bulb and internal carotid
artery according to the standard method recom-
mended by Japanese Society of Ultrasound in Medicine
[15]. Images of longitudinal sections of carotid plaque of
maximal IMT were digitally stored with RAW data. The
data were analyzed off-line by our dedicated software
(iPlaque), as described later. The study was in accordance
with the Declaration of Helsinki, and was approved by the
Institutional Review Board of the University of Tokushima.
Each subject gave informed written consent.
iPlaque analysis
In the iPlaque analysis, ultrasound attenuation was ad-
justed by 2.0 dB/mm at first. Then, each IB value was
normalized to the calibrated value by setting the IB value
of blood near the plaque to −70 dB. The edge of the
plaque of interest was manually traced, and then the
program calculated the plaque area and the average IB
value in the plaque. The area of each tissue component
was categorized in accordance with published IB thresh-
olds, and the amount of each component as a percent-
age of the whole plaque area was calculated. The IB
thresholds used were: −30.14 dB≦IB = calcification (display
Bando et al. Cardiovascular Ultrasound  (2015) 13:34 Page 2 of 8
in red); −46.18 dB≦IB < −30.14 dB = dense fibrosis (display
in yellow); −61.23 dB≦IB < −46.18 dB = fibrosis (display in
green); − IB < −61.23 dB = lipid pool (display in blue) [22].
Reproducibility
To assess measurement reproducibility, 20 patients with
ACS were selected randomly and we evaluated two dif-
ferent measurements on the 20 ACS patients. The cor-
relation between the measured values of percentage blue
area by the two observers (Observer I and Observer II)
was regarded as the inter-observer correlation. The cor-
relation between the first and second values determined
by one observer (Observer I) was regarded as the intra-
observer correlation. The coefficients of variation of
interobserver and intraobserver was 7.3 % and 6.6 %,
respectively. Also, we plotted the mean differences
against the mean of 2 measurements according to the
methods described by Bland - Altman.
Statistical analysis
Data are presented as mean ± SD. Data were tested for
normality using the Kolmogorov-Smirnov test. Continu-
ous variables were compared using unpaired Student’s
t tests or Mann–Whitney test as appropriate, whereas
categorical variables were compared using Chi-square
test or Fisher’s exact test, as appropriate. Receiver-
operating characteristic (ROC) curves were generated
to determine optimal cutoff values of continuous vari-
ables. Correlation coefficients were calculated by using
the least-squares fit (forced through zero), and Bland -
Altman analysis was used. Linear regression model
assumptions of linearity, independence of observations,
normality of error terms, homoscedasticity were all
checked. All statistical analyses were carried out with Med-
calc Software 12.7.5.0 (Ghent, Belgium). A p-value <0.05
was considered significant.
Results
Patients’ characteristics and conventional ultrasound
parameters
The clinical characteristics of the two groups of patients
are shown in Table 1. There were no significant differ-
ences in age, gender, body mass index (BMI), smoking,
left ventricular ejection fraction (LVEF), or the preva-
lence of other diseases (hypertension, hypercholesterol-
emia, diabetes mellitus). Serum low density lipoprotein
cholesterol (LDL-C) and oxidized LDL concentrations
were significantly greater in patients with ACS than in
those with SAP. There were no differences in medication
between the two groups (including antihypertensive
agents, diabetes drugs, and statins). Neither plaque area
nor maximal IMT showed significant differences be-
tween the two groups (Fig. 1a, b). The average IB value
within the plaque was greater in the ACS patients than
in the SAP patients (Fig. 1c).
Percentage tissue composition in carotid plaque
The iPlaque analysis revealed that the blue area
(expressed as a percentage) was significantly greater in
the ACS patients than in the SAP patients (Fig. 2d). The
yellow and green areas were significantly smaller in the
ACS than in the SAP group, and the red area was not
Table 1 Comparisons of patients’ characteristics between groups with acute coronary syndrome and stable angina pectoris
Acute Coronary Syndrome Stable Angina Pectoris p value
(n = 26) (n = 38)
Age (yrs) 67 ± 12 69 ± 7 0.63
Men (%) 18 (69) 28 (74) 0.58
Hypertension (%) 17 (65) 31 (82) 0.18
Hypercholesterolemia (%) 22 (85) 30 (79) 0.53
Diabetes mellitus (%) 12 (46) 19 (50) 0.69
Smoking (%) 20 (77) 29 (79) 0.89
BMI (kg/m2) 24.0 ± 3.8 24.5 ± 3.3 0.64
LVEF (%) 58 ± 10 63 ± 11 0.10
LDL-C (mg/dl) 113 ± 36 94 ± 26 0.03
HDL-C (mg/dl) 48 ± 15 54 ± 14 0.13
TG (mg/dl) 159 ± 107 121 ± 87 0.15
oxidized LDL (mg/dl) 139 ± 50 106 ± 28 0.005
eGFR (ml/min) 73 ± 22 746 ± 18 0.672
hs CRP (mg/l) 0.92 ± 1.89 0.14 ± 0.21 0.061
TG (mg/dl) 159 ± 107 121 ± 87 0.145
BMI body mass index, LVEF left ventricular ejection fraction, LDL-C low-densityllipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglyceride,
hs CRP high sensitive C reactive protein
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significantly different between the two groups (Fig. 2a, b,
c). Conventional B-mode image and color mapping of
tissue characterization by iPlaque of carotid plaques in
representative cases in both groups are shown in Fig. 3.
In these cases, the blue area was 59 % in the ACS patient
and 20 % in the SAP patient.
Parameters of iPlaque analysis for identifying ACS
Receiver operating characteristic (ROC) curves for iden-
tifying ACS in all subjects using iPlaque parameters were
constructed (Fig. 4). A blue area > 26.6 % was deter-
mined as the best criterion for identifying ACS with
88 % sensitivity and 87 % specificity. The area under the
curve for each parameter was 0.938 for percentage blue,
0.850 for green, 0.842 for yellow, and 0.713 for red. For
diagnosing ACS, the percentage blue area was better
than the percentage red and yellow (p < 0.0001,
p = 0.0180, respectively), and also tended to be better
than the percentage green (p = 0.0606).
Reproducibility
The correlation between the first and second measure-
ments by one of the observers was good (r = 0.930,
p < 0.0001). The correlation between the measured
values of percent blue area by two observers (r = 0.940,
p < 0.0001) was also good, which was similar with previous
reports [24, 25]. Bland Altman plots for reproducibility of
blue area by two observers showing a mean difference
Fig. 1 Comparisons of carotid ultrasonographic parameters (a:maximal intima-medina thickness, b:plaque area, and c:average integrated
backscatter value) between the patients
Fig. 2 Comparisons of each tissue component (a:percent red area, b:percent yellow area, c:percent green area, and d:percent blue area) of carotid
plaque determined by the iPlaque analysis in patients with acute coronarysyndrome (ACS) and stable angina pectoris (SAP): Mean ± SD is displayed
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(solid line) of −1.3 %, and Bland Altman limits (dashed
lines) of +7.6 and −10.1. The solid red line denotes bias
(mean of differences) and the dashed lines denote 95 %
limits of agreement (2 SD of the difference). Also,
Bland Altman plots for reproducibility of blue area
measured by one of the observers showing a mean
difference (solid line) of +1.7, and Bland Altman limits
(dashed lines) of +10.1 and −6.7 (Fig. 5).
Discussion
In the present study, we have examined the tissue char-
acteristics of carotid plaques in patients with ACS or
SAP, using the recently developed iPlaque imaging ana-
lytical system based on ultrasound IB data. The iPlaque
images had enough resolution quality to analyze the tis-
sue characteristics. We found that the percentage blue
area of plaque was greater in ACS patients than in SAP
patients. Thus, we have confirmed that patients with
ACS have vulnerable plaques, and that SAP patients
have plaques that are more fibrous and therefore more
stable. The study also established the usefulness and
feasibility of the iPlaque system for quantifying carotid
plaque tissue characteristics in the clinical setting.
Relationship between carotid atherosclerosis and cardiac
events
A strong association between coronary artery disease
and carotid atherosclerosis has been reported by many
investigators. As both arteries share the same systemic
environment, atherosclerotic changes in the two sites are
believed to occur to a similar degree. It has been re-
ported that IMT was significantly associated with the
presence of coronary artery disease, and the measure-
ment has been shown to be an independent predictor of
future coronary events [26]. Furthermore, the
Fig. 3 Conventional B-mode images and iPlaque analysis of carotid plaque in representative patients with acute coronary syndrome and stable
angina pectoris
Fig. 4 Receiver operating characteristic curves of the iPlaque
analysis: Each color of the graph corresponds to a different tissue
component in the carotid plaque, as described in the text
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echogenicity of carotid artery plaque has been reported
to be a predictor of the future risk of developing ACS
[15, 18, 19]. Seo et al. reported that echolucent carotid
plaques evaluated by the gray scale median were strongly
associated with ACS [18]. Two studies have evaluated
the IB values of carotid plaques and assessed its relation-
ship with coronary complications in patients with coron-
ary artery disease [19, 27]. Both found that low IB
carotid plaque was associated with an increased risk of
future events. Also, several studies indicate the useful-
ness of carotid IB values to detect the unstable plaques
and the effect of statins [28, 29]. The iPlaque images
were shown as color-coded and we could use this system
quantitative assessment of plaque vulnerability.
Ultrasound tissue characterization imaging of carotid
plaque
Evaluation of tissue characteristics of carotid plaque has
been endeavored by IB since 1983 [30]. or using gray-
scale median since 1989 [31]. In these pioneer studies,
investigators analyzed average gray-scale median or IB
value of the one ultrasonographic section of carotid
plaque [27, 28]. Consequently, color code mapping of
tissue contents in carotid plaque based of gray-scale me-
dian [16, 32] and IB value [9] has been attempted. Be-
cause the basic quality of ultrasound B-mode image has
been significantly in these days by technological
innovation, our iPlaque analysis can provide much better
spatial resolution compared to previous studies. Our sys-
tem also achieved automatic imaging processing using
custom-made software, while previous method needed
manual calculation of IB value in each region of interests
in the plaque.
Clinical implications
As the tissue characterization of coronary artery plaque
needs IB-IVUS, which requires catheterization, tissue
characterization of carotid plaque may be used as a non-
invasive surrogate procedure. Our results suggest that
patients with vulnerable coronary plaques may also have
vulnerable plaques in their carotid arteries. As iPlaque
analysis of carotid plaque is both non-invasive and quan-
titative, and enables repeated measurements to be made.
In addition, iPlaque analysis permits to judge the thera-
peutic effect of plaque stabilization easily, while IB-IVUS
is an invasive technique. We may be able to prevent the
occurrence of ACS in patients with vulnerable plaques
using iPlaque analysis if the medication stabilizes the ca-
rotid plaques. Another application might for the predic-
tion of the future risk of ACS in patients with life-style
disease and metabolic syndrome, which is currently very
difficult.
Limitations
Our sample size was small, but it was enough for our
statistical analysis. In this study, we did not examine the
feasibility of our system. In consecutive patients with 36
ACS, our iPlaque analysis could be applied in 26 (72 %)
patients. Feasibility of this method need to be examined
in future research. We analyzed data from only one
Fig. 5 Linear regression analysis and Bland-Altman analysis of blue area measured by one of the observers and two observers. a:correlation
between the first and the second measurement of blue area. b:correlation between the blue area measured by the first observer and the second
observer. c:association between the mean value and the difference in blue area measured twice by one observer. d:association between the
mean value and the difference in blue area measured by the first and the second observers
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section of plaque in highly selected patients. To assess
the plaque size and its tissue components more accur-
ately, three-dimensional ultrasound should be used with
multiple sections of two-dimensional images, or alter-
natively it would be necessary to develop a three-
dimensional linear probe for carotid ultrasound
examination. One of the major limitations is that a
calcified lesion in the near wall of the carotid artery
creates an acoustic shadow, making the analysis im-
possible. However, such a calcified lesion was usually
observed only in a more advanced stage of athero-
sclerosis. Our main target population was patients in
an early stage of atherosclerosis with some risk
factors.
Conclusions
Carotid plaques in ACS patients have a greater lipid
component and a smaller fibrous component than pla-
ques in SAP patients. Our iPlaque system, a non-
invasive imaging algorithm based on ultrasound IB, is
useful and feasible for the tissue characterization of ca-
rotid plaques in the clinical setting.
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